Your browser doesn't support javascript.
loading
Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing.
Mester, Jessica L; Jackson, Sarah A; Postula, Kristen; Stettner, Amy; Solomon, Sheila; Bissonnette, Jeffrey; Murphy, Patricia D; Klein, Rachel T; Hruska, Kathleen S.
Afiliação
  • Mester JL; Inherited Cancer Program, GeneDx, Inc., Gaithersburg, Maryland. Electronic address: jmester@genedx.com.
  • Jackson SA; Inherited Cancer Program, GeneDx, Inc., Gaithersburg, Maryland.
  • Postula K; MyGeneTeam, LLC, Miami, Florida.
  • Stettner A; MyGeneTeam, LLC, Miami, Florida.
  • Solomon S; MyGeneTeam, LLC, Miami, Florida.
  • Bissonnette J; Inherited Cancer Program, GeneDx, Inc., Gaithersburg, Maryland.
  • Murphy PD; Inherited Cancer Program, GeneDx, Inc., Gaithersburg, Maryland.
  • Klein RT; MyGeneTeam, LLC, Miami, Florida.
  • Hruska KS; Inherited Cancer Program, GeneDx, Inc., Gaithersburg, Maryland.
J Mol Diagn ; 22(3): 396-404, 2020 03.
Article em En | MEDLINE | ID: mdl-31881331

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Testes Genéticos / Proteína Supressora de Tumor p53 / Predisposição Genética para Doença / Heterozigoto / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variação Genética / Testes Genéticos / Proteína Supressora de Tumor p53 / Predisposição Genética para Doença / Heterozigoto / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article